40925-71-1

Usage

Uses

Used in Dye and Pigment Production:
6-Methoxy-2-aminophenol is utilized as a key intermediate in the synthesis of various dyes and pigments, contributing to the coloration and stability of these products in different applications.
Used in Pharmaceutical Synthesis:
In the pharmaceutical industry, 6-Methoxy-2-aminophenol serves as an intermediate for the production of various pharmaceuticals, playing a crucial role in the development of new drugs and medicines.
Used in Agrochemical Production:
6-Methoxy-2-aminophenol is also employed in the agrochemical sector, where it acts as an intermediate in the synthesis of compounds used in agriculture to protect crops and enhance yields.
Used in Chemical Research and Development:
Due to its unique chemical properties, 6-Methoxy-2-aminophenol is a valuable component in research and development efforts, particularly for creating innovative compounds and exploring new chemical reactions and processes.

Upstream product

• 15969-08-1 6-methoxy-2-nitrophenol 
• 91-66-7 N,N-diethylaniline 
• 90-05-1 2-methoxy-phenol 

Downstream Products

• 1365269-20-0 2,2,2-trifluoro-N-(2-hydroxy-3-methoxyphenyl)acetamide 
• 258532-76-2 8-hydroxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazine 
• 258532-71-7 8-methoxy-4H-benzo[1,4]oxazin-3-one 
• 888731-94-0 (4-benzyloxy-3,5-dichlorophenyl)-[8-(tert-butyldimethylsilyloxy)-2,3-dihydrobenzo[1,4]oxazin-4-yl]-methanone 
• 1630973-37-3 (3R,3aR)-phenyl 6-methoxy-4-oxo-3a,4-dihydro-3H-benzo[b]imidazo[1,5-d][1,4]oxazine-3-carboxylate 
• 1630973-77-1 methyl 5-((4R,5R)-1-(2-hydroxy-3-methoxyphenyl)-4-(methoxycarbonyl)-4,5-dihydro-1H-imidazol-5-yl)oxazole-4-carboxylate 
• 888731-91-7 2-chloro-N-(2-hydroxy-3-methoxyphenyl)-acetamide 

Relevant academic research and scientific papers

Production Method of Nitrogen-Containing Fused Ring Compounds

[Problems] The present invention provides a superior production method and a superior purification method of compounds effective for the treatment or prophylaxis of pathology showing involvement of uric acid, such as hyperuricemia, gouty tophus, acute gouty arthritis, chronic gouty arthritis, gouty kidney, urolithiasis, renal function disorder, coronary artery disease, ischemic heart disease and the like. [Means] A compound represented by the following formula [2] or a pharmaceutically acceptable salt thereof can be produced by reacting a compound represented by the following formula [3] or a salt thereof with a compound represented by the following formula [4], a salt thereof or a reactive derivative thereof. Moreover, crystallization of a compound represented by the formula [2] can be performed with industrially superior workability, and high quality crystals of a compound represented by the formula [2] can be obtained. wherein each symbol is as defined in the description.

Regulatory molecules for the 5-HT3 receptor ion channel gating system

Substituted benzoxazole derivatives which possess a nitrogen-containing heterocycle at C2 are selective partial agonists of the 5-HT3 receptor. Alteration of substituents on the benzoxazole nucleus affords both agonist-like and antagonist-like compounds, and uniquely modifies the function of the 5-HT3 receptor ion channel gating system. SAR and corroborative computational docking study for these partial agonists successfully explained structure and function of the 5-HT3 receptor.

Nitrogen-containing fused ring compounds and use thereof

A URAT1 activity inhibitor containing a nitrogen-containing fused ring compound represented by the following formula [1]: wherein each symbol is as defined in the description. The present invention is useful for the prophylaxis or treatment of pathology showing involvement of uric acid, such as hyperuricemia, gouty tophus, acute gouty arthritis, chronic gouty arthritis, gouty kidney, urolithiasis, renal function disorder, coronary artery disease, ischemic heart disease and the like.

Novel synthesis of benzoxazoles from o-nitrophenols and amines

o-Nitrophenols and o-nitroaniline were reacted with amines at 210-215°C to produce the corresponding benzoxazoles and benzimidazoles, respectively, in moderate yields. The reactions between o-nitrophenols containing a CO2Me or OMe group on their benzene rings and N,N-diethylaniline were examined to investigate the effects of the position and electronic character of these substituents on the formation of the oxazole ring.

Substituted benzoxazinorifamycin derivative and antibacterial agent containing the same

A rifamycin derivative having the formula (I): STR1 wherein R1 is hydrogen atom, methyl group or ethyl group, R2 is an alkyl group having 1 to 4 carbon atoms, and A is a group having the formula: STR2 in which n is an integer of 3 to